Distribution of fibroblast growth factor‐2 (FGF‐2) within model excisional wounds following topical application

Objective To characterise the magnitude and distribution of fibroblast growth factor‐2 (FGF‐2) following topical application in hypromellose gel and film formulations or a solution in an animal wound model, in order to assess the potential of this route for treatment of chronic wounds.

[1]  N. Medlicott,et al.  The role of topical growth factors in chronic wounds. , 2007, Current drug delivery.

[2]  N. Medlicott,et al.  Hypromellose films for the delivery of growth factors for wound healing , 2007, The Journal of pharmacy and pharmacology.

[3]  H. Tagami,et al.  Basic fibroblast growth factor treatment for various types of recalcitrant skin ulcers: Reports of nine cases , 2007, The Journal of dermatological treatment.

[4]  F. Andreopoulos,et al.  Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds. , 2006, Biomaterials.

[5]  Byung-Soo Kim,et al.  Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel. , 2006, Biomaterials.

[6]  Sha Huang,et al.  Wound dressings containing bFGF-impregnated microspheres , 2006, Journal of microencapsulation.

[7]  Y. Tabata,et al.  Accelerated wound healing through the incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis using a pressure-induced decubitus ulcer model in genetically diabetic mice. , 2005, British journal of plastic surgery.

[8]  P. Dell’Era,et al.  Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. , 2005, Cytokine & growth factor reviews.

[9]  S. Ashley,et al.  Angiogenesis in tissue-engineered small intestine. , 2003, Tissue engineering.

[10]  S. Werner,et al.  Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.

[11]  D. Sane,et al.  Abnormal angiogenesis in diabetes mellitus , 2003, Medicinal research reviews.

[12]  J. Duconge,et al.  Disposition and receptor-site binding of (125)I-EGF after topical administration to skin wounds. , 2002, Biopharmaceutics & drug disposition.

[13]  Keith Harding,et al.  Science, medicine and the future: healing chronic wounds. , 2002, BMJ.

[14]  M. Stacey,et al.  Mitogenic activity and cytokine levels in non‐healing and healing chronic leg ulcers , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[15]  L. Claesson‐Welsh,et al.  FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. , 2001, Trends in pharmacological sciences.

[16]  D. Steed,et al.  Wound healing: biologic features and approaches to maximize healing trajectories. , 2001, Current problems in surgery.

[17]  S. -. Lee,et al.  Cytokine delivery and tissue engineering. , 2000, Yonsei medical journal.

[18]  M. Botta,et al.  Fibroblast growth factors and their inhibitors. , 2000, Current pharmaceutical design.

[19]  Y. Ikada,et al.  Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. , 2000, Biomaterials.

[20]  F. Ballard,et al.  Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions. , 1999, American journal of physiology. Endocrinology and metabolism.

[21]  G R Tobin,et al.  Physiology and healing dynamics of chronic cutaneous wounds. , 1998, American journal of surgery.

[22]  M. Nimni.  Polypeptide growth factors: targeted delivery systems. , 1997, Biomaterials.

[23]  R. Kreis,et al.  Confocal laser scanning microscopy of porcine skin: implications for human wound healing studies , 1997, Journal of anatomy.

[24]  I. K. Cohen,et al.  Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. , 1996, The Journal of investigative dermatology.

[25]  T. Nakamura,et al.  Acceleration of wound healing in diabetic mice by basic fibroblast growth factor. , 1996, Biological & pharmaceutical bulletin.

[26]  R. Gamelli,et al.  Basic fibroblast growth factor mediates angiogenic activity in early surgical wounds. , 1996, Surgery.

[27]  D. M. Cooper,et al.  Determination of Endogenous Cytokines in Chronic Wounds , 1994, Annals of surgery.

[28]  G. Schultz,et al.  Growth factors and wound healing: Part II. Role in normal and chronic wound healing. , 1993, American journal of surgery.

[29]  G. Schultz,et al.  Growth factors and wound healing: biochemical properties of growth factors and their receptors. , 1993, American journal of surgery.

[30]  V. Falanga.  Chronic wounds: pathophysiologic and experimental considerations. , 1993, The Journal of investigative dermatology.

[31]  R Langer,et al.  Controlled and modulated release of basic fibroblast growth factor. , 1991, Biomaterials.

[32]  D. Rifkin,et al.  Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice , 1990, The Journal of experimental medicine.

[33]  D. Greenhalgh,et al.  PDGF and FGF stimulate wound healing in the genetically diabetic mouse. , 1990, The American journal of pathology.

[34]  Schmitter,et al.  [Advances in wound healing]. , 1951, Die Medizinische Welt.

[35]  Shingo Nakamura,et al.  Therapeutic angiogenesis induced by controlled release of fibroblast growth factor‐2 from injectable chitosan/non‐anticoagulant heparin hydrogel in a rat hindlimb ischemia model , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[36]  M. Roberts,et al.  Defining a model to predict the distribution of topically applied growth factors and other solutes in excisional full-thickness wounds. , 1999, The Journal of investigative dermatology.

[37]  G. Laurent,et al.  Mechanisms of tissue repair: from wound healing to fibrosis. , 1997, The international journal of biochemistry & cell biology.

[38]  P. Colville-Nash,et al.  Growth factors in angiogenesis: current interest and therapeutic potential. , 1997, Molecular medicine today.

[39]  Thomas A. Mustoe, MD, FACS,et al.  Pharmacologic enhancement of wound healing. , 1995, Annual review of medicine.

[40]  C. Kiritsy,et al.  Role of growth factors in cutaneous wound healing: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[41]  M. Klagsbrun,et al.  Modulation of Wound Repair by Members of the Fibroblast Growth Factor Family , 1988 .

[42]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .